Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP219991.RAo8N9H3fN-N6XA-JgrH2kKfvZ1u0DBU1ptXU_N8Pylu0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP219991.RAo8N9H3fN-N6XA-JgrH2kKfvZ1u0DBU1ptXU_N8Pylu0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP219991.RAo8N9H3fN-N6XA-JgrH2kKfvZ1u0DBU1ptXU_N8Pylu0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP219991.RAo8N9H3fN-N6XA-JgrH2kKfvZ1u0DBU1ptXU_N8Pylu0130_provenance.
- NP219991.RAo8N9H3fN-N6XA-JgrH2kKfvZ1u0DBU1ptXU_N8Pylu0130_assertion description "[In this study, resistant sublines of the histiocytic lymphoma cell line U-937 GTB and the myeloma line RPMI 8226 were developed by culturing under gradually increasing concentrations of CHS 828 until reaching 25 times the parental line EC50s.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP219991.RAo8N9H3fN-N6XA-JgrH2kKfvZ1u0DBU1ptXU_N8Pylu0130_provenance.
- NP219991.RAo8N9H3fN-N6XA-JgrH2kKfvZ1u0DBU1ptXU_N8Pylu0130_assertion evidence source_evidence_literature NP219991.RAo8N9H3fN-N6XA-JgrH2kKfvZ1u0DBU1ptXU_N8Pylu0130_provenance.
- NP219991.RAo8N9H3fN-N6XA-JgrH2kKfvZ1u0DBU1ptXU_N8Pylu0130_assertion SIO_000772 15090743 NP219991.RAo8N9H3fN-N6XA-JgrH2kKfvZ1u0DBU1ptXU_N8Pylu0130_provenance.
- NP219991.RAo8N9H3fN-N6XA-JgrH2kKfvZ1u0DBU1ptXU_N8Pylu0130_assertion wasDerivedFrom befree-20150227 NP219991.RAo8N9H3fN-N6XA-JgrH2kKfvZ1u0DBU1ptXU_N8Pylu0130_provenance.
- NP219991.RAo8N9H3fN-N6XA-JgrH2kKfvZ1u0DBU1ptXU_N8Pylu0130_assertion wasGeneratedBy ECO_0000203 NP219991.RAo8N9H3fN-N6XA-JgrH2kKfvZ1u0DBU1ptXU_N8Pylu0130_provenance.
- befree-20150227 importedOn "2015-02-27" NP219991.RAo8N9H3fN-N6XA-JgrH2kKfvZ1u0DBU1ptXU_N8Pylu0130_provenance.